ConductScience.org, home

Paper798473

The alternative pathway of complement activation.

Götze O and 1 other. Adv Immunol, 1976. Cited by 91 papers, by iCite.

Cite this record

ConductScience Library. The alternative pathway of complement activation. Papers, record 798473. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/798473

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The alternative pathway of complement activation.
PubMed
Journal
Adv Immunol
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
2.65
iCite
Revised in PubMed
2019-10-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Götze OO
2Müller-Eberhard HJH J

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C3Major topic
Complement System ProteinsMajor topic
ProperdinMajor topic
Animals
Complement C5
Electrophoresis
Esterases
Feedback
Glomerulonephritis
Glycoproteins
Guinea Pigs
Humans
Immunoglobulins
Isoelectric Point
Magnesium
Molecular Weight
Platelet Aggregation
Polysaccharides
Rabbits
Serum Globulins
Terminology as Topic

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
39195266Mononuclear Phagocytes, Cellular Immunity, and Nobel Prizes: A Historic Perspective.Cells2024https://conductscience.org/library/papers/39195266PubMed
38638432Cutting edge of genetically modified pigs targeting complement activation for xenotransplantation.Front Immunol2024https://conductscience.org/library/papers/38638432PubMed
36203396Contribution of animal models to the mechanistic understanding of Alternative Pathway and Amplification Loop (AP/AL)-driven Complement-mediated Diseases.Immunol Rev2023https://conductscience.org/library/papers/36203396PubMed
35473318The potential role of complement alternative pathway activation in hypertensive renal damage.Exp Biol Med (Maywood)2022https://conductscience.org/library/papers/35473318PubMed
32214620Antibody and complement-dependent viral neutralization.Springer Semin Immunopathol1979https://conductscience.org/library/papers/32214620PubMed
32214619Antibody mediated complement dependent lysis of virus infected cells.Springer Semin Immunopathol1979https://conductscience.org/library/papers/32214619PubMed
20941861Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.J Clin Invest2010https://conductscience.org/library/papers/20941861PubMed
20065106C5a alters blood-brain barrier integrity in experimental lupus.FASEB J2010https://conductscience.org/library/papers/20065106PubMed
19833734Improving therapeutic efficacy of a complement receptor by structure-based affinity maturation.J Biol Chem2009https://conductscience.org/library/papers/19833734PubMed
19388159Discrimination between host and pathogens by the complement system.Vaccine2008https://conductscience.org/library/papers/19388159PubMed
10704143Inhibitors of complement activity in human breast-milk: a proposed hypothesis of their physiological significance.Mediators Inflamm1999https://conductscience.org/library/papers/10704143PubMed
7395306Changes in the haemolytic activity of serum complement during acute Babesia bovis infection in cattle.Z Parasitenkd1980https://conductscience.org/library/papers/7395306PubMed
7305948Purification and characterization of subcomponent C1q of the first component of mouse complement.Biochem J1981https://conductscience.org/library/papers/7305948PubMed
7076275Handling of soluble IgA aggregates by the mononuclear phagocytic system in mice. A comparison with IgG aggregates.Immunology1982https://conductscience.org/library/papers/7076275PubMed
7040652Complement and disease: a review.J R Soc Med1982https://conductscience.org/library/papers/7040652PubMed
7007211Rheumatoid factors in mice: plaque assay for homophile and heterophile rheumatoid factors.Immunology1980https://conductscience.org/library/papers/7007211PubMed
6900632Acute phase proteins, C9, factor B, and lysozyme in recurrent oral ulceration and Behçet's syndrome.J Clin Pathol1980https://conductscience.org/library/papers/6900632PubMed
6776529Partial sequence of human complement component factor B: novel type of serine protease.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6776529PubMed
6674205Immune complexes: biochemical and biological aspects.Indian J Pediatr1983https://conductscience.org/library/papers/6674205PubMed
6390112Low molecular weight-IgM antibody in syphilis detected by Treponema pallidum immune adherence (TPIA) test.Med Microbiol Immunol1984https://conductscience.org/library/papers/6390112PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/798473

GET https://conductscience.org/api/papers/v1/798473/cited_by?page=2